16-Apr-2026
No headlines found.
Enact to Host First Quarter 2026 Earnings Call May 6th
Globe Newswire (Thu, 9-Apr 4:20 PM ET)
Genworth Financial Schedules Earnings Conference Call for May 6
Business Wire (Thu, 9-Apr 4:10 PM ET)
Enact Releases 2025 Sustainability Report
Globe Newswire (Wed, 25-Mar 11:04 AM ET)
Genworth Financial Announces Fourth Quarter 2025 Results
Business Wire (Mon, 23-Feb 4:10 PM ET)
Enact Reports Fourth Quarter and Full Year 2025 Results
Globe Newswire (Tue, 3-Feb 4:20 PM ET)
Enact Announces New $500 Million Share Repurchase Program and $0.21 Per Share Quarterly Dividend
Globe Newswire (Tue, 3-Feb 4:15 PM ET)
Business Wire (Tue, 20-Jan 8:00 AM ET)
Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.
Enact Holdings trades on the NASDAQ stock market under the symbol ACT.
As of April 16, 2026, ACT stock price declined to $41.83 with 201,088 million shares trading.
ACT has a beta of 0.48, meaning it tends to be less sensitive to market movements. ACT has a correlation of 0.09 to the broad based SPY ETF.
ACT has a market cap of $5.91 billion. This is considered a Mid Cap stock.
Last quarter Enact Holdings reported $313 million in Revenue and $1.23 earnings per share. This fell short of revenue expectation by $-4 million and exceeded earnings estimates by $.13.
In the last 3 years, ACT traded as high as $44.80 and as low as $21.81.
The top ETF exchange traded funds that ACT belongs to (by Net Assets): IJR, SDVY, VTI, AVUV, IWM.
ACT has underperformed the market in the last year with a price return of +21.0% while the SPY ETF gained +31.9%. However, in the short term, ACT had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.7% vs +1.6% return in SPY. But in the last 2 weeks, ACT shares have been beat by the market, returning +3.1% compared to an SPY return of +7.1%.
ACT support price is $41.38 and resistance is $42.54 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ACT shares will trade within this expected range on the day.